Citation

Grempler R, Thomas L, Eckhardt M, Himmelsbach F, Sauer A, Sharp DE, Bakker RA, Mark M, Klein T, Eickelmann P.: Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors. Diabetes Obes Metab, Volume 14 (1), 2012

Authors

Bakker RA, Eckhardt M, Eickelmann P., Grempler R, Himmelsbach F, Klein T, Mark M, Sauer A, Sharp DE, Thomas L

Journal

Diabetes Obes Metab

Year

2012

DOI

10.1111/j.1463-1326.2011.01517.x

PubMed

21985634

Machine-readable

REST APIRDF